ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,553Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 1111

$956K Total Retail Price of All Prescriptions

Rank: 46 out of 1111

634 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 13,251 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 566 524 1 3
FUROSEMIDE 564 472 2 6
HYDROCODONE-ACETAMINOPHEN 539 424 S3 3 1
LISINOPRIL 486 403 4 2
OMEPRAZOLE 481 414 5 4
AMLODIPINE BESYLATE 417 380 6 7
METFORMIN HCL 381 285 7 8
SIMVASTATIN 328 272 8 5
GABAPENTIN 308 235 9 10
WARFARIN SODIUM 258 222 10 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 251 219 11 23
ATORVASTATIN CALCIUM 247 232 12 15
MIRTAZAPINE 246 205 13 52
LOSARTAN POTASSIUM 237 225 14 34
METOPROLOL TARTRATE 236 204 15 12
SERTRALINE HCL 199 166 16 24
POTASSIUM CHLORIDE 197 169 17 9
DONEPEZIL HCL 194 177 18 25
CRESTOR 181 146 19 33
METOPROLOL SUCCINATE 178 152 20 20
HYDROCHLOROTHIAZIDE 161 133 21 11
ALLOPURINOL 160 154 22 36
PRAVASTATIN SODIUM 155 135 23 17
FLUOXETINE HCL 152 106 24 44
CITALOPRAM HBR 150 104 25 14
CARVEDILOL 150 127 25 21
CLONIDINE HCL 146 105 27 42
TRAMADOL HCL 143 103 28 13
NAMENDA 143 125 28 31
LABETALOL HCL 140 132 30 234
ATENOLOL 136 111 31 22
GLIMEPIRIDE 129 100 32 61
RANITIDINE HCL 117 85 33 29
TAMSULOSIN HCL 117 92 33 28
NOVOLOG 112 74 35 104
PANTOPRAZOLE SODIUM 107 95 36 50
CYMBALTA 107 74 36 40
LANTUS 105 60 38 46
DILTIAZEM 24HR CD 105 101 38 152
ROPINIROLE HCL 104 80 40 68
KLOR-CON M20 101 76 41 79
ENALAPRIL MALEATE 100 90 42 56
SPIRONOLACTONE 94 68 43 83
MELOXICAM 89 49 44 18
ZOLPIDEM TARTRATE 88 56 45 16
RISPERIDONE 87 58 46 60
CEPHALEXIN 85 66 47 89
PROMETHAZINE HCL 84 50 R 48 69
ALBUTEROL SULFATE 84 62 48 136
OLANZAPINE 84 72 48 117
ABILIFY 83 81 51 123
CARBIDOPA-LEVODOPA 82 66 52 101
VENLAFAXINE HCL ER 82 44 52 105
TRAZODONE HCL 79 48 54 32
LOSARTAN-HYDROCHLOROTHIAZIDE 78 64 55 72
LOVASTATIN 75 62 56 41
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 65 56 71
DIVALPROEX SODIUM 74 65 58 82
QUETIAPINE FUMARATE 71 32 59 76
DIOVAN 70 54 60 51
HUMALOG 69 51 61 202
PHENYTOIN SODIUM EXTENDED 67 29 62 126
DIGOXIN 67 67 62 47
FLUTICASONE PROPIONATE 66 47 64 27
CLOTRIMAZOLE-BETAMETHASONE 63 46 65 194
NEXIUM 62 36 66 26
DIOVAN HCT 61 55 67 94
AMOX TR-POTASSIUM CLAVULANATE 60 53 68 141
FAMOTIDINE 60 59 68 77
BISOPROLOL-HYDROCHLOROTHIAZIDE 59 59 70 143
BUPROPION HCL SR 59 39 70 150
POLYETHYLENE GLYCOL 3350 58 57 72 45
PLAVIX 57 47 73 49
CLOPIDOGREL 57 52 73 30
TIZANIDINE HCL 57 39 73 91
NIFEDIPINE ER 54 47 76 185
PREDNISONE 54 30 76 48
ALENDRONATE SODIUM 54 53 76 35
HALOPERIDOL 53 28 79 180
DOXAZOSIN MESYLATE 51 41 80 87
BUSPIRONE HCL 51 22 80 96
LYRICA 51 25 80 62
CELEBREX 50 45 83 81
ADVAIR DISKUS 50 28 83 43
FENTANYL 50 13 S2 83 65
TRIAMTERENE-HCTZ 50 39 83 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.